• Irinotecan Workflows for Tumor Microenvironment Assays

  2026-08-15

  Use Irinotecan (CPT-11) as a mechanistic challenge compound for linking topoisomerase I stress to viability, DNA damage, and apoptosis across colorectal cancer models. Matched organoid–stromal assembloids add a practical layer for testing how tumor microenvironment context changes drug sensitivity and resistance.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-08-14

  This guide explains how to use Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, for HMGB1 detection in Western blot, immunohistochemistry, and flow cytometry workflows. It is a research-use reagent for human, mouse, and rat samples and should not be treated as a diagnostic or therapeutic assay component.

• MG-132 and the m6A–Proteasome Axis

  2026-08-14

  MG-132 is a cell-permeable proteasome inhibitor that can do more than trigger apoptosis: it can help test how m6A-dependent RNA regulation connects to ubiquitin-mediated proteostasis. This article develops an ovarian-aging assay framework grounded in the YTHDF2/UBE3C study while distinguishing mechanistic inference from established evidence.

• 2-APB for Calcium Signaling Workflows

  2026-08-13

  2-APB provides a practical way to separate IP3 receptor-mediated calcium release from downstream store-operated calcium entry and channel effects. This workflow guide combines concentration-aware assay design with reference-study insights for calcium signaling, oxidative injury, and cardiovascular research.

• ATRX Loss Sensitizes Glioma Cells to PDGFR Inhibitors

  2026-08-13

  The reference study identifies ATRX deficiency as a potential biomarker of increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data further suggest that ATRX status may help interpret RTK inhibitor trials and guide studies combining targeted inhibition with temozolomide.

• Isorhamnetin as a PI3K/Akt Assay Probe

  2026-08-12

  Isorhamnetin is a flavonoid research compound that links PI3K/Akt activation with oxidative stress, endoplasmic reticulum stress, and apoptosis in porcine oocytes. This article translates the reference findings into practical assay decisions while defining the limits of cross-model interpretation.

• Partial BACE Inhibition and Synaptic Transmission

  2026-08-12

  Satir et al. examined whether reducing amyloid-β production through partial β-secretase inhibition disrupts synaptic transmission in primary cortical neurons. Their results indicate that Aβ secretion can fall by up to approximately 50% without measurable synaptic impairment in this model, whereas stronger inhibition reduced both Aβ secretion and synaptic transmission.

• AP-2α Suppresses MGMT in Recurrent GBM

  2026-08-11

  The reference study identifies AP-2α as a transcriptional suppressor of MGMT in recurrent glioblastoma and links this pathway to improved temozolomide-induced DNA damage. Its combination of promoter-mapping assays, resistant glioma models, and intracranial validation provides a mechanistic framework for studying TMZ resistance and MGMT-directed sensitization.

• P2RX1, CaMKII, and Mitochondrial Apoptosis in Ph+ ALL

  2026-08-11

  Li et al. identify P2RX1 as a regulator of tyrosine kinase inhibitor-induced mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia. Their data connect calcium imbalance and CaMKII activation with suppression of PI3K/Akt survival signaling, providing a mechanistic framework for studying treatment response and possible resistance in Ph+ ALL.

• Oligomycin A in Mitochondrial Bioenergetics

  2026-08-10

  Oligomycin A provides a direct way to separate ATP-linked respiration from glycolytic compensation, making it valuable in cancer metabolism research and immune-cell assays. This workflow-focused guide covers dose finding, oxygen-consumption measurements, ROS and apoptosis readouts, and the limitations of extending mitochondrial perturbation into tumor-associated macrophage biology.

• Lenalidomide in Myeloma Research: Workflow & Insights

  2026-08-09

  Build more informative myeloma experiments with Lenalidomide (CC-5013), combining immune, antiproliferative, and angiogenesis readouts instead of relying on viability alone. This workflow translates recent DOT1L–innate immunity findings into practical combination designs, controls, and troubleshooting decisions.

• LY294002 Workflow for PI3K–Mitophagy Studies

  2026-08-08

  Learn how to use LY294002 to interrogate PI3K/Akt/mTOR control of mitophagy, pyroptosis, and inflammatory cartilage injury. This practical guide combines pathway controls, assay-ready parameters, comparative interpretation, and troubleshooting for disease and cancer models.

• LY-411575 Gamma-Secretase Inhibitor Workflows

  2026-08-07

  LY-411575 enables controlled interrogation of amyloid beta production and Notch cleavage in cell-based and translational research workflows. Its sub-nanomolar potency is especially useful when Aβ measurements are paired with NICD, viability, or functional neuronal readouts to separate pathway modulation from nonspecific toxicity.

• IPR-803: Reliable uPAR Inhibitor for Tumor Invasion Assays

  2026-08-07

  This article addresses persistent challenges in cell invasion and metastasis assays, offering evidence-based guidance on using IPR-803 (SKU BA8331) as a urokinase receptor inhibitor. By grounding protocol recommendations and vendor selection in peer-reviewed data and practical workflow considerations, it empowers biomedical researchers to optimize reproducibility and translational relevance in cancer models.

• Azithromycin, Roxithromycin as Senolytics: Targeting Human F

  2026-08-06

  Ozsvari et al. (2018) identified the macrolide antibiotics Azithromycin and Roxithromycin as a new class of senolytic drugs, selectively eliminating senescent human fibroblasts. This study leverages a robust drug-repurposing assay with rigorous senescence detection, signaling the translational potential of FDA-approved compounds in aging research.

16329 records 1/1089 page Next 12345 下5页 Last page